Large-scale testing (Phase 3)Ended earlyNCT04095793
What this trial is testing
Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
Theravance Biopharma 110